Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$175M |
| 2 |
Parker-Hannifin
PH
|
+$161M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$149M |
| 4 |
McDonald's
MCD
|
+$138M |
| 5 |
Bank of America
BAC
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$253M |
| 2 |
Meta Platforms (Facebook)
META
|
+$193M |
| 3 |
Lowe's Companies
LOW
|
+$193M |
| 4 |
CME Group
CME
|
+$179M |
| 5 |
Apple
AAPL
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.85% |
| 2 | Consumer Discretionary | 12.64% |
| 3 | Healthcare | 10.98% |
| 4 | Real Estate | 6.88% |
| 5 | Industrials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
601
DELISTED
Patterson Companies, Inc.
PDCO
| $11.1M | 0.03% |
306,291
-754,290
| -71% | -$27.5M |
|
602
BP
BP
$113B
| $11.1M | 0.03% |
+287,351
| New | +$10.4M |
|
603
Itaú Unibanco
ITUB
$82.9B
| $11.1M | 0.03% |
+1,752,614
| New | +$11.2M |
|
604
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.5B
| $11M | 0.03% |
130,000
+105,000
| +420% | +$8.8M |
|
605
NetEase
NTES
$78.7B
| $11M | 0.03% |
159,695
+138,195
| +643% | +$8.63M |
|
606
CALL
Microchip Technology
MCHP
$40.3B
| $11M | 0.03% |
+250,000
| New | +$11.3M |
|
|
HPP
607
Hudson Pacific Properties
HPP
$798M
| $11M | 0.03% |
45,802
-187,998
| -80% | -$45.2M |
|
608
CALL
Take-Two Interactive
TTWO
$43.7B
| $11M | 0.03% |
+100,000
| New | +$10.9M |
|
609
CALL
Smith & Wesson
SWBI
$612M
| $10.9M | 0.03% |
+1,105,850
| New | +$12M |
|
|
MSGN
610
DELISTED
MSG Networks Inc.
MSGN
| $10.9M | 0.03% |
537,321
+42,539
| +9% | +$819K |
|
611
CALL
Check Point Software Technologies
CHKP
$13.3B
| $10.9M | 0.03% |
105,000
+65,000
| +163% | +$7.06M |
|
612
Advanced Micro Devices
AMD
$746B
| $10.8M | 0.03% |
+1,054,292
| New | +$12.3M |
|
613
Antero Midstream
AM
$10.5B
| $10.8M | 0.03% |
+547,329
| New | +$10.2M |
|
614
Acadia Pharmaceuticals
ACAD
$5.11B
| $10.8M | 0.03% |
+357,958
| New | +$11.4M |
|
615
CALL
Mondelez International
MDLZ
$82.6B
| $10.7M | 0.03% |
250,000
+85,600
| +52% | +$3.59M |
|
616
CALL
Workday
WDAY
$49.2B
| $10.7M | 0.03% |
+105,000
| New | +$11.2M |
|
|
SPPI
617
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $10.6M | 0.03% |
+560,918
| New | +$10.2M |
|
|
LADR
618
Ladder Capital
LADR
$1.27B
| $10.6M | 0.03% |
777,314
+458,124
| +144% | +$6.27M |
|
619
iShares US Real Estate ETF
IYR
$4.67B
| $10.6M | 0.03% |
+130,512
| New | +$10.6M |
|
|
MPT
620
Medical Properties Trust
MPT
$2.46B
| $10.6M | 0.03% |
+766,048
| New | +$10.4M |
|
|
ULTI
621
DELISTED
Ultimate Software Group Inc
ULTI
| $10.6M | 0.03% |
48,358
+40,468
| +513% | +$8.21M |
|
622
Teva Pharmaceuticals
TEVA
$43B
| $10.5M | 0.03% |
556,290
-1,089,636
| -66% | -$16.4M |
|
|
XHR
623
Xenia Hotels & Resorts
XHR
$1.81B
| $10.5M | 0.03% |
486,813
+218,945
| +82% | +$4.77M |
|
624
State Street SPDR S&P Metals & Mining ETF
XME
$4.71B
| $10.5M | 0.03% |
+288,801
| New | +$9.42M |
|
625
Gogo Inc
GOGO
$347M
| $10.4M | 0.03% |
+925,000
| New | +$9.84M |
|
Similar funds
Dmitry Balyasny's Q4 2017 Portfolio in Review
As of Q4 2017, Dmitry Balyasny held 2,554 positions worth $32B, up 25% from $25.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny deployed $4.77B of net new capital in Q4 2017, opening 720 new positions and adding to 686 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was American Express, an estimated $253M trimmed.
- Dmitry Balyasny's largest Q4 2017 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.
- Dmitry Balyasny added most to Aetna Inc in Q4 2017, an estimated $175M increase.
- Dmitry Balyasny's biggest Q4 2017 reduction was American Express, cutting an estimated $253M.
- Dmitry Balyasny fully exited Range Resources in Q4 2017, selling an estimated $104M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $32B portfolio in Q4 2017.
- Dmitry Balyasny opened 720 new positions and closed 529 in Q4 2017.
- Dmitry Balyasny's portfolio value rose 25% quarter-over-quarter to $32B.
Based on Balyasny Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.